GGrantIndex
Sort

40,608 grants matching prostate cancer

Mechanisms of Prostate Cancer Dormancy in the Bone Marrow Niche

$495,498
Russell S Taichman · University Of Michigan At Ann Arbor · U54 · FY2014 · CA

Molecular mechanisms of tumor-initiated premetastatic niche formation in lung str

$495,460
Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2011 · CA

MUTATIONAL LANDSCAPE OF THE Y CHROMOSOME AND PROSTATE CANCER

$495,422
Sloan-Kettering Institute For Cancer Research · · FY2018 · Department of the Army

KAPS Biotech: A novel biomarker to improve prostate cancer diagnosis

$495,303
Willie Underwood · Kaps Biotech, Inc. · R42 · FY2020 · MD

Image-guided radiation-induced permeability (IGRIP) for IGDD

$495,216
Stephen J. Kron · University Of Chicago · R01 · FY2016 · CA

Montana Cancer Consortium

$495,189
Montana Cancer Consortium · U10 · FY2003 · CA

Unravel a novel metabolic pathway orchestrating prostate cancer progression and therapeutic resistance

$495,102
Hui-Kuan Lin · Duke University · R01 · FY2024 · CA

Nutrional Epidemiology of Cancer

$495,028
Meir J Stampfer · Harvard School Of Public Health · R25 · FY2007 · CA

Illumina Genome Analyzer II

$495,000
George S. Grills · Cornell University · S10 · FY2009 · RR

Targeting IKK and HDAC Mediated IL-8 Expression in Ovarian and Prostate Cancer

$495,000
Ivana Vancurova · St. John'S University · R15 · FY2016 · CA

Interleukin-8 Regulation by Proteasome and Nuclear IkB in Cancer and Inflammation

$495,000
Ivana Vancurova · St. John'S University · R15 · FY2013 · CA

Leveraging cross-cancer shared heritability to better understand the genetic architecture of cancer

$494,993
Sara Lindstroem · University Of Washington · U01 · FY2023 · CA

Clinical trials employing cancer vaccine combination therapies

$494,990
James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines

$494,990
James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

GENETIC EPIDEMIOLOGY OF PROSTATE CANCER AGGRESSIVENESS

$494,925
Case Western Reserve University · R01 · FY2002 · CA

Nipple Fluid Hormone Levels and Breast Cancer Risk

$494,862
Seema Ahsan Khan · Northwestern University At Chicago · R01 · FY2007 · CA

Discovery of a stem cell driving breast cancer spine metastases

$494,785
Matthew Blake Greenblatt · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA

A pooling project on alcohol use and risk of cancers with inconsistent prior evidence, with an emphasis in non-smokers.

$494,761
Pietro Ferrari · International Agency For Res On Cancer · R01 · FY2017 · AA

Growth Factors and Lethal Prostate Cancer Signature

$494,706
Meir J Stampfer · Brigham And Women'S Hospital · R01 · FY2013 · CA

Exosome separation and digital resolution detection of blood-based nucleic acid biomarkers for noninvasive therapeutic diagnostics in cancer

$494,678
Brian T. Cunningham · University Of Illinois At Urbana-Champaign · R01 · FY2023 · EB

VPAC1 Recpetor-Targeted PET Imaging of Prostate Cancer

$494,661
Mathew L Thakur · Thomas Jefferson University · R01 · FY2013 · CA

NYU COOPERATIVE PROSTATE CANCER TISSUE RESOURCE

$494,617
New York University School Of Medicine · U01 · FY2004 · CA

EPITHELIAL CELL PROFILING IN DEVELOPING EXCURRENT DUCT

$494,568
Massachusetts General Hospital · R01 · FY2003 · HD

EPITHELIAL CELL PROFILING IN DEVELOPING EXCURRENT DUCT

$494,568
Massachusetts General Hospital · R01 · FY2002 · HD

NGF recruits nerve fibers to reprogram an immunosuppressive microenvironment in melanoma

$494,541
Xiao-Fan Wang · Duke University · R01 · FY2023 · CA